The Application dimension of the AI Medical Imaging Software for Chronic Cerebrovascular Diseases segmentation isolates four principal use‑cases: Ischemic Stroke Detection, Hemorrhagic Stroke Detection, Vascular Malformation Assessment, and Perfusion Analysis. Ischemic detection, driven by high prevalence of acute occlusive events, commands the largest share, accounting for roughly 40 % of total spend, as hospitals prioritize rapid thrombolytic decision support. Hemorrhagic detection follows at 25 %, reflecting the critical need for precise bleed quantification to guide neurosurgical intervention. Vascular malformation assessment, covering aneurysms and arteriovenous malformations, contributes 20 % of market revenue, propelled by expanding screening programs in high‑risk cohorts. Perfusion analysis, which evaluates cerebral blood flow dynamics, occupies the remaining 15 % and is gaining traction through integration with advanced CT‑ and MR‑based perfusion protocols. Collectively, these application segments delineate demand drivers, pricing elasticity, and adoption velocity, thereby shaping the overall market size for AI‑enabled cerebrovascular imaging solutions.